Keywords

anxiety, caregivers, depression, heart failure, motivational interviewing, quality of life, sleep

 

Authors

  1. Locatelli, Giulia MSN, RN
  2. Rebora, Paola PhD, MS
  3. Occhino, Giuseppe MS
  4. Ausili, Davide PhD, RN
  5. Riegel, Barbara PhD, RN, FAAN, FAHA
  6. Cammarano, Andrea MS
  7. Uchmanowicz, Izabella PhD, RN, FESC, FHFA
  8. Alvaro, Rosaria MSN, RN, FESC, FAAN
  9. Vellone, Ercole PhD, RN, FESC, FAAN
  10. Zeffiro, Valentina PhD, RN

Abstract

Background: Better caregiver contribution to self-care in heart failure is associated with better patient outcomes. However, caregiver contribution to self-care is also associated with high anxiety and depression, poor quality of life, and poor sleep in caregivers. It is still unclear whether interventions that encourage caregivers to contribute more to patient self-care might increase caregivers' anxiety and depression and decrease their quality of life and sleep.

 

Objective: The aim of this study was to assess the impact of a motivational interview intervention aimed at improving caregiver contribution to self-care in heart failure on caregivers' anxiety, depression, quality of life, and sleep.

 

Methods: This is a secondary outcome analysis of the MOTIVATE-HF trial. Patients with heart failure and their caregivers were randomized into arm 1 (motivational interview to patients), arm 2 (motivational interview to patients and caregivers), and arm 3 (standard care). Data were collected between June 2014 and October 2018. The article has been prepared following the Consolidated Standards of Reporting Trials checklist.

 

Results: A sample of 510 patient-caregiver dyads was enrolled. Over the year of the study, the levels of anxiety, depression, quality of life, and sleep in caregivers did not significantly change among the 3 arms.

 

Conclusions: Motivational interview aimed at improving caregiver contribution to self-care does not seem to increase caregiver anxiety and depression, nor decrease their quality of life and sleep. Thus, such an intervention might be safely delivered to caregivers of patients with heart failure, although further studies are needed to confirm our findings.